SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Holley Inc. f/k/a Empower Ltd. – (HLLY; HLLY.WT; EMPW; EMPW-WT)
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Holley Inc. f/k/a Empower Ltd. (“Holley” or the “Company”) (NYSE: HLLY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 8
Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023
Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p < 0.0001) compared to placeboResults also showed statistically significant rapid and sustained reductions i
Statement by the Prime Minister on Poland’s National Independence Day
OTTAWA, ON, Nov. 11, 2023 /CNW/ – The Prime Minister, Justin Trudeau, today issued the following statement on Poland’s National Independence Day: “Today, I join Polish communities in Canada and around the world in celebrating the anniversary of Poland’s independence. “O
Chroma Medicine Presents Preclinical In Vivo Data Showing Durable Cholesterol Reduction with a PCSK9-Targeted Epigenetic Editor at the 2023 AHA Scientific Sessions
This first presentation of non-human primate (NHP) data highlights the potential of Chroma’s epigenetic editors to achieve specific and robust results after a single administration, without cutting or nicking the DNA In NHPs, Chroma’s epigenetic editor achieved efficient reductions in bl
LAS VEGAS TACO BELL CANTINA REVS UP FOR THE BIG RACE WITH TIGHT TURNS AND TACOS WATCH PARTY
Limited spots with track views on Saturday, November 18 LAS VEGAS, Nov. 11, 2023 /PRNewswire/ — World Class racing is revving up for an exhilarating debut in the streets of Las Vegas, and the iconic Las Vegas Taco Bell Cantina, owned by Diversified Restaurant Group, will be the ultimate desti
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. – KVUE
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fifth Third Bancorp – FITB
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Fifth Third Bancorp (“Fifth Third” or the “Company”) (NASDAQ: FITB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adobe, Inc. – ADBE
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Adobe, Inc. (“Adobe” or the “Company”) (NASDAQ: ADBE). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 798
Pet Supplies Plus and Natural Balance® Join Forces to Gift $50,000 Veteran’s Day Donation to Patriot PAWS
Largest Pet Retail Franchise and Premium Pet Food Maker Help Provide Service Dogs to Deserving Veterans PROSPER, Texas, Nov. 11, 2023 /PRNewswire/ — Pet Supplies Plus, the largest and most trusted pet retail franchise, has once again joined forces with Natural Balance® to raise awareness of t
Kyverna Therapeutics Congratulates the Teams at the Universities of Bochum and Magdeburg for a Late Breaker Case Report in a Patient with Refractory Myasthenia Gravis Treated with Investigational KYV-101
The severely disabled and treatment-refractory patient was discharged without symptoms three weeks after KYV-101 infusion and was fully mobile 60 days after, with no observed adverse events related to CAR T-cell therapy The late breaker abstract was presented on November 11, 2023 at the 96th Congres
